M1A.2191 Drug-induced chronic gout, unspecified shoulder, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Shoulder, with Tophus (tophi)

Summary

Drug-induced chronic gout, unspecified shoulder, with tophus is a form of arthritis affecting the shoulder joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the shoulder joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense shoulder pain, often with swelling and redness
• Persistent warmth and tenderness in the affected shoulder
• Formation of tophi (hard, painless lumps) around the shoulder joint
• Stiffness and limited range of motion in the shoulder
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging studies. A healthcare provider assesses symptoms, reviews medication history, and may order blood tests to measure uric acid levels. Joint fluid analysis or imaging (e.g., X-ray, ultrasound) can confirm the presence of urate crystals or tophi.

Treatment Options

Treatment focuses on reducing uric acid levels, managing pain, and preventing further crystal deposition. This may include discontinuing or adjusting the causative medication, prescribing urate-lowering therapies (e.g., allopurinol), and using anti-inflammatory drugs for flare-ups. In some cases, surgical removal of tophi may be necessary.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess for complications. Long-term adherence to treatment improves outcomes and reduces recurrence.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and increased tophi formation. Severe cases can result in joint deformity or reduced mobility.

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood).
• Stay hydrated to support uric acid excretion.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if experiencing severe or worsening shoulder pain, swelling, or signs of infection (e.g., fever, redness). Prompt care is important to prevent complications and adjust treatment as needed.

Tips for Medical Coders

This code (M1A.2191) specifies drug-induced chronic gout affecting the unspecified shoulder with tophus. Documentation should clearly indicate the shoulder involvement, the presence of tophi, and the drug-induced etiology. Ensure clinical notes support the diagnosis and specify the anatomic site and presence of tophi for accurate coding.